For the June quarter, Clean Science’s revenue increased by 8% from the same quarter last year to ₹240 crore, while Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) increased by 5% on a year-on-year basis to ₹00 crore.
Also Read: Sumitomo Chemicals Q1 Results: Strong revenue growth, better profitability aids margin expansion
Margins for the quarter narrowed by 100 basis points to 41.7% from 42.8% last year, while net profit increased by 6% from the year-ago quarter. Over 25% of the company’s topline came from newer launches, while the management said that there were market share gains seen by the company during this quarter.The management also expressed caution on the Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) growth guidance of 18% to 20% for the full year, stating that it could be between 15% to 18%, but more clarity can emerge at the end of the second quarter. However, the management did express optimism for the second half of the current financial year, particularly for the fourth quarter.
Clean Science and Technology is one of the few global companies dedicated to the development of newer technologies using in-house catalytic processes that are both eco-friendly and cost-effective. It manufactures functionally critical speciality chemicals, FMCG Chemicals, and Pharmaceutical Intermediates.
Also Read: Tata Chemicals Q1 net profit zooms 68% to ₹252 cr despite revenue dip, margins expand
Shares of Clean Science and Technology Ltd ended at ₹1,181.20, down by ₹8.30, or 0.70%, on the BSE.
